CYduct Diagnostics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CYDX research report →
About the company
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses.
- CEO
- Dom L. Gatto
- IPO
- 2000
- Employees
- 3
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $2.20M
- P/E
- -6.29
- P/S
- 33.51
- P/B
- -0.72
- EV/EBITDA
- -9.75
- Div Yield
- 0.00%
- Gross Margin
- 60.66%
- Op Margin
- -458.90%
- Net Margin
- -532.19%
- ROE
- 11.90%
- ROIC
- 12.81%
- Revenue
- $70.69K · -16.33%
- Net Income
- $-413,614 · 1.06%
- EPS
- $-0.08 · 1.74%
- Op Income
- $-363,217
- FCF YoY
- 58.83%
- 52W High
- $2.90
- 52W Low
- $0.20
- 50D MA
- $0.48
- 200D MA
- $0.57
- Beta
- -0.96
- Avg Volume
- 52
Get TickerSpark's AI analysis on CYDX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CYDX coverage
Recent articles, reports, and earnings notes.
No research on CYDX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CYDX report →Similar companies
Peers in the same neighborhood.